《全日總結》恆指跌7點 車股弱 藥明生物逆市揚逾5%
港股在內地股市走軟下表現反覆造淡。恆指今早低開67點,早段下跌其後曾倒升117點見23,863點,尾市曾跌151點一度低見23,595點,其後收復失地。全日跌7點或0.03%,收23,739點;國指升3點或0.04%,收8,369點;恆生科技指數跌5點或0.1%,收5,619點。大市全日成交總額1,296.24億元,滬、深港通南下交易分別淨流入15.17億及12.37億元人民幣。
科技股方面,騰訊(00700.HK)升1.5%報460元,阿裏巴巴(09988.HK)跌1.6%報125.6元,美團(03690.HK)升0.7%報208元,小米(01810.HK)跌1.9%報18.16元,京東(09618.HK)升1.8%報275元,百度(09888.HK)跌3.5%報146.5元,嗶哩嗶哩(09626.HK)、快手(01024.HK)及商湯(00020.HK)各升2.5%至3.3%,攜程(09961.HK)則跌6.3%。
世茂(00813.HK)接連遭標普及穆迪下調信貸評級,股價低開後倒升0.5%報5.63元。龍湖(00960.HK)附屬發行不逾28億人民幣公司債,股價升1%報41.25元。其餘內房股方面,中海外(00688.HK)及合景泰富(01813.HK)各升3.4%及4.2%。恆大(03333.HK)跌0.6%報1.72元,同系恆大物業(06666.HK)跌0.7%。物管股碧桂園服務(06098.HK)升4%。
印尼指明天審查煤炭出口禁令,電力股潤電(00836.HK)及華電國際(01071.HK)各升5%及3%。資源及金屬類股上升,五礦資源(01208.HK)及中鋁(02600.HK)各升5.4%及5.5%。江銅(00358.HK)及中國宏橋(01378.HK)各升3%及3.5%。
醫藥股續見炒怍,康哲藥業(00867.HK)、藥明生物(02269.HK)及藥明康德(02359.HK)各升5.5%至6%,信達生物(01801.HK)升4%。康希諾醫藥(06185.HK)遭股東折讓配股套現逾5億元,股價跌5.5%。
汽車股下跌,吉利(00175.HK)、長汽(02333.HK)及小鵬汽車(09868.HK)各跌3.6%至4.4%,理想汽車(02015.HK)跌5.3%。鋰電池材料商贛鋒鋰業(01772.HK)亦跌逾2%。內需股農夫山泉(09633.HK)、萬洲(00288.HK)及安踏(02020.HK)各跌2.6%至2.9%,潤啤(00291.HK)跌3.8%。
其他藍籌方面,匯控(00005.HK)升0.5%報51.95元,港交所(00388.HK)跌1.2%報452.6元。友邦(01299.HK)跌1.8%報78.6元。內銀股建行(00939.HK)及招行(03968.HK)各升1.9%及1.6%。創科(00669.HK)及長實集團(01113.HK)各升2.6%及3.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.